Therapeutic Areas

Our expertise in these niche, narrow-field therapeutic areas drives innovation and faster drung launches across our European territories.

Haematology & Oncology

Within haematology, we work with products and therapies serving a handful of key rare diseases.

Genetic & Metabolic Disorders

Our commercialisation expertise spans a range of genetic & metabolic disorders and conditions.

CNS & Neurology

Our experience also extends to rare, hereditary disorders affecting the central nervous system.

“Working for rare diseases and orphan drugs is immensely valuable because it allows us to directly impact patients' lives by facilitating access to essential treatments. Advocating for those with unmet medical needs and often overlooked conditions, ensuring they receive the latest therapeutic innovations, holds profound meaning. Moreover, partnering with the scientific community to support and educate them in treating these patients is exciting, as it enables us to make a tangible difference in improving health outcomes and enhancing the quality of life for those we serve.”

Latest articles

Abacus Medicine Pharma Services and Biocodex join forces to optimize the distribution of Diacomit® in Denmark, Norway and Sweden
Medical affairs challenges for orphan drugs: the key to a winning KOL engagement strategy
How real-world evidence is changing Health Technology Assessment (HTA) submissions